Kerimbayev A 1
1. Breaking the Barrier: SARS-CoV-2 Infections in Wild and Companion Animals and Their Implications for Public Health
2. Assessment of Peste des Petits Ruminants Antibodies in Vaccinated Pregnant Ewes of Kazakh Breed Fine-Fleeced and Determination of the Decreasing Trend of Maternal Immunity in Their Lambs
3. Efficient Serum-Free Rabies Virus Propagation Using BSR and Vero Cell Lines: A Comparative Evaluation of BioNOC II® Macrocarriers in the BelloStage™-3000 Bioreactor Versus Conventional Microcarriers
4. Phylogenetic analysis of a 2024 Sheeppox virus isolate from the Almaty region of Kazakhstan and investigation of its pathogenicity in merino sheep
5. Duration of immunity against infectious rhinotracheitis and bovine viral diarrhea after vaccination in calves in southern region of Kazakhstan
6. The Influence of the Associated Inactivated Vaccine Against Infectious Rhinotracheitis and Bovine Viral Diarrhea on the Formation and Duration of Colostral Immunity in Kazakh Whiteheaded Calves
7. Coding Complete Genome Sequence of the SARS-CoV-2 Virus Strain, Variant B.1.1, Sampled from Kazakhstan
8. Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up
9. Development and Preclinical Evaluation of a Lyophilized Vaccine Against Equine Herpesvirus Type 4 (EHV-4)
10. Safety and Immunogenicity of the Live Attenuated Vaccine QazCOVID-Live Against Coronavirus Infection COVID-19: Pre-Clinical Study Results
11. SARS-CoV-2 Delta Variant Does Not Sustain Replication in Companion Dogs: Insights from an Experimental Infection Model
12. Susceptibility and Transmission Dynamics of Peste des Petits Ruminants Virus in Domestic and Wild Ruminants: Experimental Insights from Kazakhstan
13. Field Trials of Live and Inactivated Camelpox Vaccines in Kazakhstan
14. Development of an ELISA Using Recombinant Chimeric SM Protein for Serological Detection of SARS-CoV-2 Antibodies
15. A novel influenza vector-based vaccine expressing ESAT-6 and TB10.4 confers immunity and protection against Bovine tuberculosis in guinea pigs and calves
16. Complete genome sequence of SARS-CoV-2 isolated from a dog in Kazakhstan
17. Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19
18. Pre-Clinical Safety and Immunogenicity Study of a Coronavirus Protein-Based Subunit Vaccine for COVID-19
19. Analysis of the Dynamics of Key Socio-Economic Indicators of the Republic of Kazakhstan (2001–2024)
20. Regional Income Inequality in Kazakhstan: Assessments of the Impact of Healthcare and Macroeconomic Instability
21. The impact of tourism services development on income inequality in Kazakhstan’s regions
22. Near-Complete Genome Sequence of a SARS-CoV-2 Variant B.1.1.7 Virus Strain Isolated in Kazakhstan
23. Development of the Inactivated QazCovid-in Vaccine: Protective Efficacy of the Vaccine in Syrian Hamsters
24. Prevalence of Bluetongue and the distribution of Culicoides species in northern and southern regions of Kazakhstan in 2023–2024
1